Cost-effectiveness of IGRA/QFT-Plus for TB screening of migrants in Oman

Copyright © 2020. Published by Elsevier Ltd..

OBJECTIVE: To estimate the cost of a screening program for identifying latent tuberculosis (TB) infections in migrants to Oman.

METHODS: A Markov model was used to estimate the cost of screening using an interferon-gamma release assay (IGRA) applied to all migrants from high TB endemic countries, followed by preventive TB treatment.

RESULTS: The model compared seven different scenarios, with a comparison of the direct cost and the quality-adjusted life-years (QALYs) saved.

CONCLUSIONS: IGRA testing followed by 3 months of preventive treatment with rifapentine/isoniazid (3HP) was the most cost-effective intervention.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:92S

Enthalten in:

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 92S(2020) vom: 01. März, Seite S72-S77

Sprache:

Englisch

Beteiligte Personen:

Al Abri, Seif [VerfasserIn]
Kowada, Akiko [VerfasserIn]
Yaqoubi, Fatma [VerfasserIn]
Al Khalili, Sulien [VerfasserIn]
Ndunda, Nduku [VerfasserIn]
Petersen, Eskild [VerfasserIn]

Links:

Volltext

Themen:

Cost
DAILYs
Isoniazid
Journal Article
Latent tuberculosis
Rifampin
Rifapentine
Screening
V83O1VOZ8L
VJT6J7R4TR
XJM390A33U

Anmerkungen:

Date Completed 10.06.2020

Date Revised 10.06.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.ijid.2020.03.010

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM307599450